TNF and breast neoplasm: Making use of shRNA to TNFα and the N-terminal fragment of tmTNFα, the authors of this investigation have concluded that reduced expression of tmTNFα improved the sensitivity of breast tumor cells to doxorubicin, and that the activities of tmTNFα in resistance were meditated by NF-κB and Erk (111).